Sight Sciences to Present at 31st Annual Piper Jaffray Healthcare Conference
Summary
MENLO PARK, Calif.--(BUSINESS WIRE)--Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that the company’s management is scheduled to participate in the upcoming Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel in New York City. Paul Badawi, CEO, and Jesse Selnick, CFO, are slated to present on Wednesday, Dec. 4, 2019 at 1:30 p.m. EST. Founded in 2011, Sight Sciences has developed, and is now commercial with intelligently designed and engineered products that target the underlying causes of the worlds most prevalent eye diseases. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemms canal, and collector channels) with a single device and single corneal incision. TearCares innovative, "equipment-light" product design and the intuitive procedure it facilitates create a highly attractive clinical and economic model for eye care providers.